Brief: Solvonis Therapeutics Says SVN-114 Selected As Lead Candidate For PTSD Discovery Programme
10/03/2026 07:37
March 10 (Reuters) - Solvonis Therapeutics PLC SVNS.L: SOLVONIS THERAPEUTICS PLC: SVN-114 SELECTED AS LEAD CANDIDATE FOR PTSD DISCOVERY PROGRAMME Source text: ID:nRSJ9244Va Further company coverage: SVNS.L ((Reuters.Briefs@thomsonreuters.com;))